Prediction of Hepatic Efflux Transporter-Mediated Drug Interactions: When Is it Optimal to Measure Intracellular Unbound Fraction of Inhibitors?

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of General Medical Sciences of the National Institutes of Health (R01 GM041935)

This publication has 12 references indexed in Scilit: